Risk of Renal Toxicities With Carfilzomib In Patients With Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled Trials

被引：0
|
作者：
Ball, Somedeb [1 ]
Behera, Tapas Ranjan [2 ]
Adhikari, Nimesh [1 ]
Anwer, Faiz [3 ]
Chakraborty, Rajshekhar [3 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Internal Med, Boston, MA 02115 USA
[3] Cleveland Clin, Taussig Canc Ctr, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷
关键词：
multiple myeloma; carfilzomib; renal adverse events; meta-analysis; MM;
D O I：
10.1016/j.clml.2019.07.323
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-262
引用
收藏
页码：S332 / S332
页数：1
相关论文
共 50 条
  • [31] A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of pulmonary toxicities in patients with advanced breast cancer treated with everolimus.
    Swarup, Sriman
    Thein, Kyaw Zin
    Sultan, Anita
    Yendala, Rachana
    Hardwicke, Fred L.
    Jones, Catherine
    Awasthi, Sanjay
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [32] Therapeutic Hypothermia and the Risk of Hemorrhage A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Wang, Chih-Hung
    Chen, Nai-Chuan
    Tsai, Min-Shan
    Yu, Ping-Hsun
    Wang, An-Yi
    Chang, Wei-Tien
    Huang, Chien-Hua
    Chen, Wen-Jone
    MEDICINE, 2015, 94 (47) : e2152
  • [33] A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of hypophosphatemia, hypertension, and hematological toxicities in patients with cancer treated with regorafenib.
    Igid, Henry Palangdao
    Thein, Kyaw Zin
    Sultan, Anita
    Swarup, Sriman
    Awasthi, Sanjay
    Jones, Catherine
    Hardwicke, Fred L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [34] Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials
    D. Rosenberg
    T. Avni
    G. Tsvetov
    A. Gafter-Gvili
    T. Diker-Cohen
    Osteoporosis International, 2021, 32 : 413 - 424
  • [35] Risk of gastrointestinal and hepatic toxicities in patients with metastatic solid tumors treated with cabozantinib: A systematic review and meta-analysis of randomized controlled trials.
    Zaw, Myo
    Thein, Kyaw Zin
    Han, Myat M.
    Igid, Henry Palangdao
    Hardwicke, Fred L.
    Tijani, Lukman
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31)
  • [36] Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials
    D. Rosenberg
    T. Avni
    G. Tsvetov
    A. Gafter-Gvili
    T. Diker-Cohen
    Osteoporosis International, 2021, 32 : 2131 - 2131
  • [37] Efficacy of probiotics in multiple sclerosis: a systematic review of preclinical trials and meta-analysis of randomized controlled trials
    Jiang, Jinchi
    Chu, Chuanqi
    Wu, Caie
    Wang, Chen
    Zhang, Chengcheng
    Li, Tiantian
    Zhai, Qixiao
    Yu, Leilei
    Tian, Fengwei
    Chen, Wei
    FOOD & FUNCTION, 2021, 12 (06) : 2354 - 2377
  • [38] Thalidomide treatment for patients with previously untreated multiple myeloma: a meta-analysis of randomized controlled trials
    Gao, Minjie
    Kong, Yuanyuan
    Wang, Houcai
    Xie, Bingqian
    Yang, Guang
    Gao, Lu
    Zhang, Yiwen
    Zhan, Fenghuang
    Dai, Bojie
    Tao, Yi
    Shi, Jumei
    TUMOR BIOLOGY, 2016, 37 (08) : 11081 - 11098
  • [39] Efficacy of Isatuximab Combination Regimens in Patients with Relapsed and Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials
    Htut, Thura Win
    Phyu, Ei Moe
    Win, Myint Aung
    Thein, Kyaw Zin
    BLOOD, 2023, 142
  • [40] Impact of mineralocorticoid receptor antagonist in renal transplant patients: a systematic review and meta-analysis of randomized controlled trials
    Ahmed Mohamed Abdelhakim
    Mohamed Abd-ElGawad
    Journal of Nephrology, 2020, 33 : 529 - 538
12345